Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Form design

A more compHcated structure doesn t always mean a more compHcated disconnection when rings are being formed. Design a synthesis for TM 251. [Pg.80]

Rubisco exists in three forms an inactive form designated E a carbamylated, but inactive, form designated EC and an active form, ECM, which is carbamylated and has Mg at its active sites as well. Carbamylation of rubisco takes place by addition of COg to its Lys ° e-NHg groups (to give e—NH—COO derivatives). The COg molecules used to carbamylate Lys residues do not become substrates. The carbamylation reaction is promoted by slightly alkaline pH (pH 8). Carbamylation of rubisco completes the formation of a binding site for the Mg that participates in the catalytic reaction. Once Mg binds to EC, rubisco achieves its active CM form. Activated rubisco displays a Ai, for CO2 of 10 to 20... [Pg.732]

Off the shelf buildings are generally of set modular form designed to a standard set of criteria. The available degree of variation may be limited, but they are perfectly suitable for several industrial uses. [Pg.43]

Prototyping basically provides a 3-D model suitable for use in the preliminary evaluation of form, design, performance, and material processing of products, molds, dies, etc. When properly used this automatic/fast system can accelerate product development, improve product quality, and time to the market for a product. [Pg.447]

PIB exists either as a low mw (about 12,000) viscous or atactic liq or as a cryst matl of about 1.00,000 mw. In this latter form the iso tactic (chain) type configuration predominates over the atactic and amorph forms (Ref 8). Since the isotactic form is the form designated by mil spec (Ref 2), its parameters are presented below ... [Pg.808]

The rationale of the dosage form design (e.g., if a drug is rapidly destroyed in solution at a pH of 2 or below, the design of an oral product must enable the drug to get through the stomach without substantial dissolution)... [Pg.26]

As discussed previously, drug absorption may be impaired or improved when food is present in the GIT. Food may reduce the rate or extent of absorption by virtue of reduced gastric-emptying rate, which is particularly important for compounds unstable in gastric fluids and for dosage forms designed to release drug... [Pg.62]

WJ Westlake. The design and analysis of comparative blood-level trails In J Swarbrick, ed. Current Concepts in the Pharmaceutical Sciences Dosage Form Design and Bioavailability. Philadelphia, PA Lea Febiger, 1973. [Pg.101]

M. Rowland, Effect of some physiologic factors on bioavailability of oral dosage forms, in Dosage Form Design and Bioavailability (J. Swarbrick, Ed.), Lea Febiger, Philadelphia, 1973, pp. 181-222. [Pg.144]

FS Horn, JJ Miskel. Enhanced drug dissolution rates for a series of drugs as a function of dosage form design. Lex Sci 8(1) 18-26, 1971. [Pg.383]

A. Biological Factors Influencing Oral Sustained-Release Dosage Form Design... [Pg.505]

Mass transfer phenomena exist everywhere in nature and are important in the pharmaceutical sciences. We may think of drug synthesis preformulation studies dosage form design and manufacture and drug absorption, distribution, metabolism, and excretion. Mass transfer plays a significant role in each. Mass transfer is referred to as the movement of molecules caused not only by diffusion but also by convection [1],... [Pg.40]

In order to design the best form for their needs, users must first define what data they wish to collect and which factors are of the greatest importance. In addition, all the usual factors in form design need to be considered (e.g., size, layout, color, print type, spacing, flow of questions, boxes, language, and instructions). A pilot to test the form should be carried out before formal introduction and use. [Pg.848]

Consideration should be given to what happens to the form once it is returned. Form design will be affected depending upon whether it is intended to serve as a direct entry document (i.e., the data elements closely match the data entry screens), or whether a transcription document will be used. [Pg.848]

Ashford M (2002) Bioavailability—Physiochemical and Dosage Form Factors In Pharmaceutics the Science of Dosage Form Design. In M Aulton (Ed.), Pharmaceutics. The Science of Dosage Form Design. 2nd Ed. Churchill Livingstone, pp 234-252. [Pg.69]


See other pages where Form design is mentioned: [Pg.226]    [Pg.254]    [Pg.411]    [Pg.224]    [Pg.475]    [Pg.224]    [Pg.232]    [Pg.87]    [Pg.121]    [Pg.599]    [Pg.26]    [Pg.26]    [Pg.27]    [Pg.52]    [Pg.340]    [Pg.515]    [Pg.238]    [Pg.407]    [Pg.546]    [Pg.501]    [Pg.798]    [Pg.462]    [Pg.492]    [Pg.846]    [Pg.848]    [Pg.848]    [Pg.883]    [Pg.114]    [Pg.172]    [Pg.15]    [Pg.16]   
See also in sourсe #XX -- [ Pg.883 ]




SEARCH



Forming design

© 2024 chempedia.info